A study to look at how safe different doses of a new medicine called “DSTA4637S” were for patients – and how this medicine was processed through the body
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
Infectious Diseases Bacterial Infection
For the latest version of this information please go to www.forpatients.roche.com